Morbid Obesity — Cost Analysis of Bariatric Surgery in an Employee-based Healthcare System Following Surgery Coverage
Citation(s)
6 CDC. Obesity and overweight trends. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/index.htm
Ackroyd R, Mouiel J, Chevallier JM, Daoud F Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006 Nov;16(11):1488-503.
Buffington CK, Cowan GSM, Jr Gastric Bypass in the Treatment of Diabetes, Hypertension and Lipid/lipoprotein Abnormalities of the Morbidly Obese. In Deitel M (ed.): Companion Volume to Obesity Surgery for the Morbidly Obese Patient. 2000 by FD Publicatio
Clegg A, Colquitt J, Sidhu M, Royle P, Walker A Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord. 2003 Oct;27(10):1167-77. Review.
Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK Surgery for morbid obesity. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003641. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD003641.
Finkelstein EA, Brown DS A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care. 2005 Oct;11(10):641-6.
Malone M, Alger-Mayer SA Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother. 2005 Apr;39(4):637-42. Epub 2005 Mar 1.
McGee DL; Diverse Populations Collaboration Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005 Feb;15(2):87-97.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.